Our next journal club features two papers on the topic of Longitudinal Data, will be held on the 16th September 2020 from 4-5pm BST.
Please click here to view the flyer.
REGISTER HERE: https://attendee.gotowebinar.com/register/2180330867722920973
Please join us to hear Florian Lasch (Hannover Medical School, Germany) and Mutamba Kayembe (Maastricht University, Netherlands) present their recent work.
The webinar will be chaired by Michael O’Kelly (IQVIA).
Florian Lasch (Hannover Medical School, Germany):- Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols
Authors: Sebastian Häckl, Armin Koch & Florian Lasch
Pharmaceutical Statistics, 2019; volume 18, Issue 6, Pages 636-644.
200916_empirical evaluation of EMA guideline on missing values - MMRM specifications_final
Mutamba Kayembe (Maastricht University, Netherlands):- Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results
Author: Mutamba T. Kayembe, Shahab Jolani, Frans E. S. Tan & Gerard J. P. van Breukelen
Pharmaceutical Statistics. Early view.
Access the slides here.
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
